Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Return on Capital Employed (2022 - 2025)

Centessa Pharmaceuticals (CNTA) has disclosed Return on Capital Employed for 4 consecutive years, with 0.4% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed fell 2.0% to 0.4% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.4% through Dec 2025, down 2.0% year-over-year, with the annual reading at 0.35% for FY2025, 14.0% up from the prior year.
  • Return on Capital Employed for Q4 2025 was 0.4% at Centessa Pharmaceuticals, up from 0.48% in the prior quarter.
  • The five-year high for Return on Capital Employed was 0.34% in Q3 2024, with the low at 0.53% in Q1 2023.
  • Average Return on Capital Employed over 4 years is 0.46%, with a median of 0.48% recorded in 2025.
  • The sharpest move saw Return on Capital Employed increased 17bps in 2024, then fell -15bps in 2025.
  • Over 4 years, Return on Capital Employed stood at 0.5% in 2022, then fell by -4bps to 0.52% in 2023, then increased by 28bps to 0.38% in 2024, then fell by -5bps to 0.4% in 2025.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 0.4%, 0.48%, and 0.43% for Q4 2025, Q3 2025, and Q2 2025 respectively.